NICHIREI CORPORATION品牌介绍

浏览量：1720

NICHIREI CORPORATION

品牌简介

日立公司于1983年开始从事生物科学业务，生产抗白细胞单克隆抗体（CD抗体）。
日立生物科技有限公司（以下简称“日立生物”）于2005年4月1日重组，其母公司日立公司采用控股公司制度接替日立的生物科技业务。日立生物的使命是通过提供基于其先进技术的高质量产品和服务，为全球生物产业的发展做出贡献，包括作为一家专业公司的医疗、化妆品和医疗保健业务。

Nichirei Corporation had started bioscience business as a manufacture of Anti-Leukocytes Monoclonal antibodies (CD Antibodies) in 1983.

Nichirei Biosciences Inc. (hereinafter called "Nichirei Bio") was reorganized on April 1,2005 succeeding Nichirei's bioscience business adopting the holding company system by its parent company, Nichirei Corporation. Nichirei Bio's mission is to contribute to the development of the global Bio-industries including medical, cosmetic and healthcare business as a specialized company by offering high-quality products and services based on its advanced technology.

Main product